BioNexus Gene Lab Corp.BGLC

$2.61+0.09 (+3.57%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$6M
Micro-cap
-98%
2021 — today
10-Year Price
-99%
2021 — today
52-Week Range
$1.94$11.14
Current $2.61· 7%

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Valuation in context

P/E ratio
-1.8
N/A
Not meaningful — company is unprofitable
P/B ratio
0.8
Below average
Below the 10-year average
FCF Yield
-18.8%
Around average
Around the 10-year average
Free · No credit card needed

Get alerted when BGLC is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.